ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Mark D. Iannettoni
Richard I. Whyte
Mark B. Orringer
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Quint, L. E.
Right arrow Articles by Orringer, M. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Quint, L. E.
Right arrow Articles by Orringer, M. B.

Ann Thorac Surg 1996;62:246-250
© 1996 The Society of Thoracic Surgeons

Original Articles: General Thoracic

Distribution of Distant Metastases From Newly Diagnosed Non-Small Cell Lung Cancer

Leslie E. Quint, MD, Srinivas Tummala, MD, Louis J. Brisson, MD, Isaac R. Francis, MD, Alexander S. Krupnick, MD, Ella A. Kazerooni, MD, Mark D. Iannettoni, MD, Richard I. Whyte, MD, Mark B. Orringer, MD

Department of Radiology and Section of Thoracic Surgery, Department of Surgery, University of Michigan Medical Center, Ann Arbor, Michigan

Accepted for publication February 24, 1996.

Background. The purpose of our study was to determine the incidence and locations of M1 disease at presentation in patients with non-small cell lung cancer to help design appropriate preoperative imaging algorithms.

Methods. All patients with non-small cell lung cancer seen between 1991 and 1993 were identified, and records were reviewed. For patients with M1 disease, the sites of distant metastases and the methods of diagnosis were recorded.

Results. Of 348 patients identified, 276 (79%) had M0 disease and 72 (21%) had M1 disease. In 40 of 72 patients (56%), M1 disease was detected via chest or abdominal computed tomography (CT). Brain, bone, liver, and adrenal glands were the most common sites of metastatic disease, in decreasing order. Brain metastases often occurred as an isolated finding, although isolated liver metastases were uncommon.

Conclusions. M1 disease was common at presentation, and was often detectable via chest CT. The incremental yield of abdominal CT over chest CT was very small, and therefore abdominal CT is not an effective method of screening for metastases if chest CT has been performed.




This article has been cited by other articles:


Home page
 JCOHome page
D. B. Costa, J. A. Parker, and S. T. Schumer
Modern Treatment of Lung Cancer: CASE 3. Non-Metastatic Bilateral F-18 Fluorodeoxyglucose Avid Adrenal Glands in Non-Small-Cell Lung Cancer
J. Clin. Oncol., October 20, 2005; 23(30): 7740 - 7742.
[Full Text] [PDF]

Home page
 JCOHome page
D. Lardinois, W. Weder, M. Roudas, G. K. von Schulthess, M. Tutic, H. Moch, R. A. Stahel, and H. C. Steinert
Etiology of Solitary Extrapulmonary Positron Emission Tomography and Computed Tomography Findings in Patients With Lung Cancer
J. Clin. Oncol., October 1, 2005; 23(28): 6846 - 6853.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
L. Schrevens, N. Lorent, C. Dooms, and J. Vansteenkiste
The Role of PET Scan in Diagnosis, Staging, and Management of Non-Small Cell Lung Cancer
Oncologist, November 1, 2004; 9(6): 633 - 643.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
T. Sioris, R. Jarvenpaa, P. Kuukasjarvi, H. Helin, S. Saarelainen, and M. Tarkka
Comparison of computed tomography and systematic lymph node dissection in determining TNM and stage in non-small cell lung cancer
Eur. J. Cardiothorac. Surg., March 1, 2003; 23(3): 403 - 408.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. G. Spiro and J. C. Porter
Lung Cancer--Where Are We Today?: Current Advances in Staging and Nonsurgical Treatment
Am. J. Respir. Crit. Care Med., November 1, 2002; 166(9): 1166 - 1196.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
N. Hollings and P. Shaw
Diagnostic imaging of lung cancer
Eur. Respir. J., April 1, 2002; 19(4): 722 - 742.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
J.A. Verschakelen, J. Bogaert, and W. De Wever
Computed tomography in staging for lung cancer
Eur. Respir. J., February 1, 2002; 19(35_suppl): 40S - 48s.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
J.F. Vansteenkiste
Imaging in lung cancer: positron emission tomography scan
Eur. Respir. J., February 1, 2002; 19(35_suppl): 49S - 60s.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
V. Ambrogi, G. Tonini, and T. C. Mineo
Prolonged Survival After Extracranial Metastasectomy From Synchronous Resectable Lung Cancer
Ann. Surg. Oncol., September 1, 2001; 8(8): 663 - 666.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
J.F. Vansteenkiste and S.G. Stroobants
The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology
Eur. Respir. J., April 1, 2001; 17(4): 802 - 820.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
J. Deslauriers and J. Gregoire
Clinical and Surgical Staging of Non-Small Cell Lung Cancer
Chest, April 1, 2000; 117(4_suppl_1): 96S - 103S.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1996 by The Society of Thoracic Surgeons.